EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs
Authors:
- Karla RubioKarla Rubio
- Alejandro Molina-HerreraAMAlejandro Molina-Herrera
- Andrea Pérez-GonzálezAndrea Pérez-González
- Hury Viridiana Hernández-GaldámezHHHury Viridiana Hernández-Galdámez
- Carolina Piña-VázquezCPCarolina Piña-Vázquez
- Tania Araujo-RamosTATania Araujo-Ramos
- Indrabahadur SinghISIndrabahadur Singh
Open Access
- 1 August 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (15) , 12302
Abstract
Fibrosis is a condition characterized by the excessive accumulation of extracellular matrix proteins in tissues, leading to organ dysfunction and failure. Recent studies have identified EP300, a histone acetyltransferase, as a crucial regulator of the epigenetic changes that contribute to fibrosis. In fact, EP300-mediated acetylation of histones alters global chromatin structure and gene expression, promoting the development and progression of fibrosis. Here, we review the role of EP300-mediated epigenetic regulation in multi-organ fibrosis and its potential as a therapeutic target. We discuss the preclinical evidence that suggests that EP300 inhibition can attenuate fibrosis-related molecular processes, including extracellular matrix deposition, inflammation, and epithelial-to-mesenchymal transition. We also highlight the contributions of small molecule inhibitors and gene therapy approaches targeting EP300 as novel therapies against fibrosis.Keywords
Funding Information
- Consejo de Ciencia y Tecnología del Estado de Puebla (240/2023)
- CONACYT-DAAD Fellowship (240/2023)
- Emmy Noether grant (240/2023)
- DFG (240/2023)
- German Cancer Research Center (240/2023)
This publication has 113 references indexed in Scilit:
- Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulationNature Structural & Molecular Biology, 2013
- p300 Is Elevated in Systemic Sclerosis and Its Expression Is Positively Regulated by TGF-β: Epigenetic Feed-Forward Amplification of FibrosisJournal of Investigative Dermatology, 2013
- Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer AgentsMolecular Cancer Therapeutics, 2013
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Scraping fibrosis: Expressway to the core of fibrosisNature Medicine, 2011
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule InhibitorChemistry & Biology, 2010
- CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53Proceedings of the National Academy of Sciences, 2009
- Prediction of All-Cause Mortality From Global Longitudinal Speckle StrainCirculation: Cardiovascular Imaging, 2009
- Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, PlumbaginJournal of Biological Chemistry, 2009
- Peroxisome proliferator‐activated receptor‐γ abrogates Smad‐dependent collagen stimulation by targeting the p300 transcriptional coactivatorThe FASEB Journal, 2009